Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addressing Drug Resistance in Cancer: A Team Medicine Approach.
Kulkarni P, Mohanty A, Bhattacharya S, Singhal S, Guo L, Ramisetty S, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Gupta N, Kim P, Babikian R, Rajurkar S, Subbiah S, Tan T, Nguyen D, Merla A, Kollimuttathuillam SV, Phillips T, Baik P, Tan B, Vashi P, Shrestha S, Leach B, Garg R, Rich PL, Stewart FM, Pisick E, Salgia R. Kulkarni P, et al. Among authors: mirzapoiazova t. J Clin Med. 2022 Sep 27;11(19):5701. doi: 10.3390/jcm11195701. J Clin Med. 2022. PMID: 36233569 Free PMC article.
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer.
Ramisetty S, Kulkarni P, Bhattacharya S, Nam A, Singhal SS, Guo L, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Pisick E, Subbiah S, Rajurkar S, Massarelli E, Salgia R, Mohanty A. Ramisetty S, et al. Among authors: mirzapoiazova t. J Clin Med. 2023 Jan 11;12(2):599. doi: 10.3390/jcm12020599. J Clin Med. 2023. PMID: 36675528 Free PMC article.
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, Kulkarni P, Villaflor V, Arvanitis L, Hamilton S, Afkhami M, Pillai R, Armstrong B, Erhunmwunsee L, Massarelli E, Sattler M, Amini A, Salgia R. Zhao D, et al. Among authors: mirzapoiazova t. Cancers (Basel). 2022 Oct 8;14(19):4933. doi: 10.3390/cancers14194933. Cancers (Basel). 2022. PMID: 36230855 Free PMC article.
Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations.
Reckamp KL, McQuerry JA, Mambetsariev I, Pharaon R, Yost SE, Fricke J, Mirzapoiazova T, Pillai RK, Khan Z, Fakih M, Yuan Y, Koczywas M, Massarelli E, Kulkarni P, Pal SK, Sattler M, Bild A, Salgia R. Reckamp KL, et al. Among authors: mirzapoiazova t. Future Sci OA. 2020 Nov 25;7(2):FSO662. doi: 10.2144/fsoa-2020-0159. Future Sci OA. 2020. PMID: 33437521 Free PMC article.
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Arvanitis LD, Atri P, Muschen M, Tissot FLH, Miser J, Kovach JS, Sattler M, Batra SK, Kulkarni P, Salgia R. Mirzapoiazova T, et al. Mol Cancer Ther. 2021 Oct;20(10):1820-1835. doi: 10.1158/1535-7163.MCT-21-0013. Epub 2021 Jul 12. Mol Cancer Ther. 2021. PMID: 34253596 Free PMC article.
51 results